Spots Global Cancer Trial Database for Glutamine for the Prevention of Radiation Toxicity in Subjects Conserving Therapy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Glutamine for the Prevention of Radiation Toxicity in Subjects Conserving Therapy
Official Title: Glutamine for the Prevention of Radiation Toxicity in Subjects Undergoing Breast Conserving Therapy
Study ID: NCT02012608
Conditions
Study Description
Brief Summary: This study is a single-centered, double-blind, two-arm randomized study to determine if oral glutamine will reduce radiation toxicity for the subjects undergoing Breast Conserving Therapy.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
Contact Details
Name: Loverd Peacock, MD
Affiliation: University of Arkansas
Role: PRINCIPAL_INVESTIGATOR
Name: Yihong Kaufmann, PhD
Affiliation: University of Arkansas
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
